What were the key changes approved for CME Group's stock plans?

Shareholders approved amendments to the Omnibus Stock Plan, extending its term to June 30, 2022, introducing new performance metrics, and altering change of control provisions so that performance-based awards will vest at the greater of actual performance or target level. The Employee Stock Purchase Plan also saw its share availability increased to 100,000 and its expiration date pushed to June 30, 2022.

How will the board structure change as a result of the shareholder vote?

The company's Certificate of Incorporation and Bylaws were amended to phase out the classified board structure. Starting with the 2014 Annual Meeting, all directors will be elected annually, moving away from staggered terms.

What was the shareholder turnout and how did they vote on key proposals?

Shareholder turnout was very strong, with approximately 83% of outstanding shares represented. The election of directors, ratification of the independent auditor, advisory vote on executive compensation, and the approved stock plan amendments all received significant shareholder support. However, a shareholder proposal on proxy access did not pass.

What impact do the changes to the Omnibus Stock Plan's change of control provisions have?

The amendments ensure that performance-based awards granted after the amendment will vest upon a change of control at a level that is at least the target performance, or higher if actual performance at the time of the change of control is greater. This provides a stronger incentive for executives to remain with the company or ensures compensation is awarded in significant corporate events.

CME 8-K: Material Agreements, Shareholder Matters & More

Summary

CME Group Inc. filed an 8-K report detailing material events from its Annual Meeting of Shareholders held on May 23, 2012. The primary focus of this report is the shareholder approval of significant amendments to key equity-based compensation plans and corporate governance documents. Investors will note the extension and enhancement of the Omnibus Stock Plan and Employee Stock Purchase Plan, including changes to vesting triggers in the event of a change of control, which may impact executive compensation and retention strategies. Additionally, shareholders approved amendments to the company's Certificate of Incorporation and Bylaws to phase out the classified board structure by 2014, moving towards annual director elections. These changes reflect a strategic shift in corporate governance and compensation practices. Shareholder participation was robust, with approximately 83% of outstanding shares represented at the meeting, indicating strong engagement. Key proposals, including the approval of executive compensation and the independent auditor, passed with substantial support. However, a shareholder proposal regarding proxy access did not receive sufficient votes. The outcomes of these votes are crucial for understanding shareholder sentiment and the future direction of CME Group's governance and incentive structures.

Key Highlights

1Shareholders approved amendments to the Omnibus Stock Plan, extending its term to June 30, 2022, adding new performance metrics, and modifying change of control provisions for performance-based awards.
2Amendments to the Employee Stock Purchase Plan were approved, increasing the share pool from 40,000 to 100,000 and extending its expiration to June 30, 2022.
3Shareholders approved amendments to the Certificate of Incorporation and Bylaws to phase out the classified board structure, with each director to be elected to a one-year term starting at the 2014 Annual Meeting.
4A significant majority of shareholders ratified the appointment of Ernst & Young LLP as the company's independent public accounting firm for 2012.
5Advisory vote on executive compensation for named executive officers was approved by a substantial margin.
6A shareholder proposal regarding Proxy Access failed to receive sufficient support.
7High shareholder turnout (approximately 83%) indicates strong engagement in company matters.

CME GROUP INC. 8-K Report, Material Agreement (May 29, 2012)

Summary

Key Highlights

Frequently Asked Questions